Allianz SE Has $23.10 Million Holdings in UnitedHealth Group Incorporated $UNH

Allianz SE increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 74,049 shares of the healthcare conglomerate’s stock after purchasing an additional 16,016 shares during the period. Allianz SE’s holdings in UnitedHealth Group were worth $23,101,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Good Life Advisors LLC lifted its holdings in shares of UnitedHealth Group by 396.7% during the 2nd quarter. Good Life Advisors LLC now owns 4,883 shares of the healthcare conglomerate’s stock worth $1,524,000 after acquiring an additional 3,900 shares during the period. ABN Amro Investment Solutions acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $10,362,000. Cherokee Insurance Co acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $1,809,000. Police & Firemen s Retirement System of New Jersey boosted its position in shares of UnitedHealth Group by 3.2% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 138,189 shares of the healthcare conglomerate’s stock worth $43,111,000 after purchasing an additional 4,254 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after buying an additional 675,075 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 3.6%

Shares of UnitedHealth Group stock opened at $339.18 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The stock has a market capitalization of $307.25 billion, a P/E ratio of 17.70, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The stock’s 50-day simple moving average is $347.08 and its 200 day simple moving average is $320.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. During the same period last year, the business earned $7.15 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Royal Bank Of Canada raised their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Jefferies Financial Group lifted their price target on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Finally, Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.